<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Interleukin-3 (IL-3) is an experimental agent used to ameliorate <z:hpo ids='HP_0001875'>neutropenia</z:hpo> in patients receiving chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Arterial thrombotic episodes after use of IL-3 have not been reported previously </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The case of a patient with Stage III <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the breast who developed <z:hpo ids='HP_0002615'>hypotension</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> cerebellar artery and superior mesenteric artery <z:mp ids='MP_0005048'>thrombosis</z:mp> after receiving chemotherapy and treatment with IL-3 is reported </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: To the authors' knowledge, this is the first patient with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> reported after treatment with IL-3 </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSIONS: Interleukin-3 may be associated with increased propensity for <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>